Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

In this first episode, join our clinical development and market access experts who discuss the role of biomarker research, discovery, and patient access in advancing precision oncology to date. Biomarkers have been central to improving patient outcomes and guiding treatment guidelines in lung, breast, and blood cancers. With that backdrop, our experts discuss the role of large-scale data sets and real-world evidence in furthering precision oncology research and improving patient outcomes in more types of cancer. 
Dr. Gwyn Bebb, Senior Vice President and Global Therapeutic Head of Oncology 
Wyatt Gotbetter, Senior Vice President Worldwide, Access Consulting